Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014.

ABSTRACT:

Background

The objective of this study was to describe changes in testosterone prescribing following a 2014 US Food and Drug Administration (FDA) safety communication and how changes varied by physician characteristics.

Methods

Data were extracted from a 20% random sample of Medicare fee-for-service administrative claims data from 2011 through 2019. The sample included 1,544,604 unique male beneficiaries who received evaluation and management (E&M) services from 58,819 unique physicians that prescribed testosterone between 2011 and 2013. Patients were categorized based on presence of coronary artery disease (CAD) and non-age-related hypogonadism. Physician characteristics were identified in the OneKey database and included specialty and affiliations with teaching hospitals,

SUBMITTER: Sankar A 

PROVIDER: S-EPMC12396602 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature